TABLE OF CONTENTS
Volume 29, Issue S1 (February 2009)
Top of page
Introduction
Top of pageReviews
Commentary on the bilirubin supplement
D K Stevenson
J Perinatol 29: S2-S3; doi:10.1038/jp.2008.220
Synopsis report from the pilot USA Kernicterus Registry
V K Bhutani and L Johnson
J Perinatol 29: S4-S7; doi:10.1038/jp.2008.210
Biological risks for neurological abnormalities associated with hyperbilirubinemia
D Brites, A Fernandes, A S Falcão, A C Gordo, R F M Silva and M A Brito
J Perinatol 29: S8-S13; doi:10.1038/jp.2008.214
Calculated free bilirubin levels and neurotoxicity
M J Daood, A F McDonagh and J F Watchko
J Perinatol 29: S14-S19; doi:10.1038/jp.2008.218
Kernicterus in the 21st century: frequently asked questions
V K Bhutani and L Johnson
J Perinatol 29: S20-S24; doi:10.1038/jp.2008.212
Clinical report from the pilot USA Kernicterus Registry (1992 to 2004)
L Johnson, V K Bhutani, K Karp, E M Sivieri and S M Shapiro
J Perinatol 29: S25-S45; doi:10.1038/jp.2008.211
The need for neonatal glucose-6-phosphate dehydrogenase screening: a global perspective
M Kaplan and C Hammerman
J Perinatol 29: S46-S52; doi:10.1038/jp.2008.216
Systems changes to prevent severe hyperbilirubinemia and promote breastfeeding: pilot approaches
A R Stark and C M Lannon
J Perinatol 29: S53-S57; doi:10.1038/jp.2008.215
Neonatal hyperbilirubinemia management: a model for change FREE
C Lazarus and R N Avchen
J Perinatol 29: S58-S60; doi:10.1038/jp.2008.217
